Funding for this research was provided by:
Korea Institute of Oriental Medicine (K13011 and K17122)
Received: 13 May 2017
Accepted: 30 May 2018
First Online: 15 June 2018
Ethics approval and consent to participate
: This study was approved by the IRB of the Daejeon Oriental Hospital, Daejeon University (approval No. djomc-112). KMDs explained the context of the clinical trial, including possible benefits and harms, and obtained written informed consent from the participants.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.